A Phase 1 observational study of gut microbiota in pyrotinib-induced diarrhea
Recruiting NCT07264985
Study Description
Understanding how gut bacteria may influence diarrhea in breast cancer patients taking pyrotinib
Study Details
- Registry ID:
- NCT07264985
- Conditions:
- Breast Cancer, Drug-Related Side Effects, Diarrhea
- Phase:
- Target Enrollment:
- 60 participants
- Start Date:
- Age Range:
- 18–75 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Hubei Cancer Hospital
Wuhan, Hubei, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.